Literature DB >> 28148611

Reducing Acute Kidney Injury Due to Contrast Material: How Nurses Can Improve Patient Safety.

Peggy Lambert1,2,3,4,5,6,7,8,9, Kristine Chaisson1,2,3,4,5,6,7,8,9, Susan Horton1,2,3,4,5,6,7,8,9, Carmen Petrin1,2,3,4,5,6,7,8,9, Emily Marshall1,2,3,4,5,6,7,8,9, Sue Bowden1,2,3,4,5,6,7,8,9, Lynn Scott1,2,3,4,5,6,7,8,9, Sheila Conley1,2,3,4,5,6,7,8,9, Janette Stender1,2,3,4,5,6,7,8,9, Gertrude Kent1,2,3,4,5,6,7,8,9, Ellen Hopkins1,2,3,4,5,6,7,8,9, Brian Smith1,2,3,4,5,6,7,8,9, Anita Nicholson1,2,3,4,5,6,7,8,9, Nancy Roy1,2,3,4,5,6,7,8,9, Brenda Homsted1,2,3,4,5,6,7,8,9, Cindy Downs1,2,3,4,5,6,7,8,9, Cathy S Ross1,2,3,4,5,6,7,8,9, Jeremiah Brown.   

Abstract

BACKGROUND: Acute kidney injury due to contrast material occurs in 3% to 15% of the 2 million cardiac catheterizations done in the United States each year.
OBJECTIVE: To reduce acute kidney injury due to contrast material after cardiovascular interventional procedures.
METHODS: Nurse leaders in the Northern New England Cardiovascular Disease Study Group, a 10-center quality improvement consortium in Maine, New Hampshire, and Vermont, formed a nursing task force to reduce acute kidney injury due to contrast material after cardiovascular interventional procedures. Data were prospectively collected January 1, 2007, through June 30, 2012, on consecutive nonemergent patients (n = 20 147) undergoing percutaneous coronary interventions.
RESULTS: Compared with baseline rates, adjusted rates of acute kidney injury among the 10 centers were significantly reduced by 21% and by 28% in patients with baseline estimated glomerular filtration rate less than 60 mL/min per 1.73 m2. Key qualitative system factors associated with improvement included use of multidisciplinary teams, standardized fluid orders, use of an intravenous fluid bolus, patient education about oral hydration, and limiting the volume of contrast material.
CONCLUSIONS: Standardization of evidence-based best practices in nursing care may reduce the incidence of acute kidney injury due to contrast material. ©2017 American Association of Critical-Care Nurses.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28148611      PMCID: PMC5557383          DOI: 10.4037/ccn2017178

Source DB:  PubMed          Journal:  Crit Care Nurse        ISSN: 0279-5442            Impact factor:   1.708


  39 in total

1.  Persistent nephrogram after administration of an isoosmolar contrast medium.

Authors:  Irene Koneth; Dominik Weishaupt; Esther B Bachli
Journal:  Nephrol Dial Transplant       Date:  2004-06       Impact factor: 5.992

2.  Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis.

Authors:  Mauro Maioli; Anna Toso; Mario Leoncini; Michela Gallopin; Nicola Musilli; Francesco Bellandi
Journal:  Circulation       Date:  2012-05-16       Impact factor: 29.690

3.  Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions.

Authors:  Mauro Moscucci; Eva Kline Rogers; Cecelia Montoye; Dean E Smith; David Share; Michael O'Donnell; Ann Maxwell-Eward; William L Meengs; Anthony C De Franco; Kirit Patel; Richard McNamara; John G McGinnity; Sandeep M Jani; Sanjaya Khanal; Kim A Eagle
Journal:  Circulation       Date:  2006-02-06       Impact factor: 29.690

4.  Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography.

Authors:  Santo Morabito; Valentina Pistolesi; Giulia Benedetti; Angelo Di Roma; Riccardo Colantonio; Massimo Mancone; Gennaro Sardella; Loredana Cibelli; Mariacarmela Ambrosino; Francesca Polistena; Alessandro Pierucci
Journal:  J Nephrol       Date:  2012 Nov-Dec       Impact factor: 3.902

5.  Changing practice to prevent contrast-induced nephropathy.

Authors:  Michele L Yellen; Martha D Buffum
Journal:  J Vasc Nurs       Date:  2014-03

6.  Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions.

Authors:  Wojciech Wróbel; Władysław Sinkiewicz; Marcin Gordon; Anita Woźniak-Wiśniewska
Journal:  Kardiol Pol       Date:  2010-09       Impact factor: 3.108

7.  Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality.

Authors:  Giancarlo Marenzi; Emilio Assanelli; Jeness Campodonico; Gianfranco Lauri; Ivana Marana; Monica De Metrio; Marco Moltrasio; Marco Grazi; Mara Rubino; Fabrizio Veglia; Franco Fabbiocchi; Antonio L Bartorelli
Journal:  Ann Intern Med       Date:  2009-02-03       Impact factor: 25.391

8.  Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.

Authors:  R G Cigarroa; R A Lange; R H Williams; L D Hillis
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

9.  Reducing contrast-induced acute kidney injury using a regional multicenter quality improvement intervention.

Authors:  Jeremiah R Brown; Richard J Solomon; Mark J Sarnak; Peter A McCullough; Mark E Splaine; Louise Davies; Cathy S Ross; Harold L Dauerman; Janette L Stender; Sheila M Conley; John F Robb; Kristine Chaisson; Richard Boss; Peggy Lambert; David J Goldberg; Deborah Lucier; Frank A Fedele; Mirle A Kellett; Susan Horton; William J Phillips; Cynthia Downs; Alan Wiseman; Todd A MacKenzie; David J Malenka
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-07-29

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  1 in total

1.  Effects and Mechanism of Salvianolic Acid B on the Injury of Human Renal Tubular Epithelial Cells Induced by Iopromide.

Authors:  Shu-Jun Dong; Xin-Yue Gao; Ming-Xin Pei; Ting Luo; Dong Fan; Yan-Ling Chen; Jun-Feng Jin; Xiao-Duo Zhao
Journal:  Front Pharmacol       Date:  2021-12-31       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.